Zynex Total Assets 2006-2019 | ZYXI
Zynex total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Zynex Annual Total Assets (Millions of US $) |
|
|---|---|
| 2019 | $28 |
| 2018 | $19 |
| 2017 | $9 |
| 2016 | $4 |
| 2015 | $4 |
| 2014 | $7 |
| 2013 | $17 |
| 2012 | $26 |
| 2011 | $22 |
| 2010 | $16 |
| 2009 | $12 |
| 2008 | $11 |
| 2007 | $7 |
| 2006 | $3 |
| 2005 | $1 |
| Zynex Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2019-12-31 | $28 |
| 2019-09-30 | $25 |
| 2019-06-30 | $22 |
| 2019-03-31 | $19 |
| 2018-12-31 | $19 |
| 2018-09-30 | $13 |
| 2018-06-30 | $11 |
| 2018-03-31 | $9 |
| 2017-12-31 | $9 |
| 2017-09-30 | $6 |
| 2017-06-30 | $4 |
| 2017-03-31 | $4 |
| 2016-12-31 | $4 |
| 2016-09-30 | $5 |
| 2016-06-30 | $4 |
| 2016-03-31 | $4 |
| 2015-12-31 | $4 |
| 2015-09-30 | $5 |
| 2015-06-30 | $5 |
| 2015-03-31 | $6 |
| 2014-12-31 | $7 |
| 2014-09-30 | $10 |
| 2014-06-30 | $11 |
| 2014-03-31 | $16 |
| 2013-12-31 | $17 |
| 2013-09-30 | $23 |
| 2013-06-30 | $24 |
| 2013-03-31 | $25 |
| 2012-12-31 | $26 |
| 2012-09-30 | $26 |
| 2012-06-30 | $25 |
| 2012-03-31 | $24 |
| 2011-12-31 | $22 |
| 2011-09-30 | $21 |
| 2011-06-30 | $19 |
| 2011-03-31 | $17 |
| 2010-12-31 | $16 |
| 2010-09-30 | $15 |
| 2010-06-30 | $13 |
| 2010-03-31 | $14 |
| 2009-12-31 | $12 |
| 2009-09-30 | $12 |
| 2009-06-30 | $12 |
| 2009-03-31 | $12 |
| 2008-12-31 | $11 |
| 2008-09-30 | $14 |
| 2008-06-30 | $11 |
| 2008-03-31 | $9 |
| 2007-12-31 | $7 |
| 2007-09-30 | $5 |
| 2007-06-30 | $4 |
| 2007-03-31 | $3 |
| 2006-12-31 | $3 |
| 2006-09-30 | $2 |
| 2006-06-30 | $2 |
| 2006-03-31 | $2 |
| 2005-12-31 | $1 |
| 2005-09-30 | $1 |
| 2005-06-30 | $1 |
| 2005-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.338B | $0.045B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $131.482B | 23.01 |
| Medtronic (MDT) | Ireland | $120.468B | 16.20 |
| Stryker (SYK) | United States | $59.680B | 19.28 |
| Boston Scientific (BSX) | United States | $42.738B | 19.25 |
| Baxter (BAX) | United States | $40.475B | 0.00 |
| Coloplast (CLPBY) | Denmark | $29.624B | 45.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $29.586B | 0.00 |
| Terumo (TRUMY) | Japan | $24.707B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $24.477B | 0.00 |
| ResMed (RMD) | United States | $20.528B | 35.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.596B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.397B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.257B | 0.00 |
| Insulet (PODD) | United States | $11.048B | 675.96 |
| Bio-Rad Laboratories (BIO) | United States | $9.648B | 45.09 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.714B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.668B | 19.18 |
| Perrigo (PRGO) | Ireland | $6.275B | 11.44 |
| GN STORE NORD (GNNDY) | Denmark | $5.486B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.097B | 0.00 |
| Haemonetics (HAE) | United States | $5.078B | 31.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Quidel (QDEL) | United States | $3.950B | 34.67 |
| ICU Medical (ICUI) | United States | $3.899B | 25.46 |
| Neogen (NEOG) | United States | $3.088B | 52.31 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.652B | 0.00 |
| NuVasive (NUVA) | United States | $2.447B | 18.92 |
| Agios Pharmaceuticals (AGIO) | United States | $2.403B | 0.00 |
| Envista Holdings (NVST) | United States | $2.359B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.316B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.599B | 26.93 |
| AtriCure (ATRC) | United States | $1.227B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.204B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.197B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.075B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.879B | 0.00 |
| Aphria (APHA) | $0.879B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $0.820B | 16.21 |
| VAREX IMAGING (VREX) | United States | $0.770B | 15.99 |
| InMode (INMD) | Israel | $0.705B | 0.00 |
| Cerus (CERS) | United States | $0.702B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.642B | 0.00 |
| PetIQ (PETQ) | United States | $0.606B | 16.50 |
| Omeros (OMER) | United States | $0.602B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.549B | 32.63 |
| OraSure Technologies (OSUR) | United States | $0.504B | 62.54 |
| Quanterix (QTRX) | United States | $0.482B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.481B | 10.82 |
| LeMaitre Vascular (LMAT) | United States | $0.458B | 25.80 |
| Surmodics (SRDX) | United States | $0.455B | 52.34 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.363B | 0.00 |
| Owens & Minor (OMI) | United States | $0.347B | 9.50 |
| HEXO (HEXO) | $0.310B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.301B | 12.12 |
| Utah Medical Products (UTMD) | United States | $0.292B | 20.88 |
| Repro-Med Systems (KRMD) | United States | $0.291B | 183.00 |
| MacroGenics (MGNX) | United States | $0.286B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.212B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.192B | 117.38 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.162B | 18.30 |
| Rockwell Medical (RMTI) | United States | $0.151B | 0.00 |
| United Health Products (UEEC) | United States | $0.148B | 0.00 |
| Evolus (EOLS) | United States | $0.139B | 0.00 |
| Bovie Medical (APYX) | United States | $0.124B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.124B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.110B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 6.76 |
| Chimerix (CMRX) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.072B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.069B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.069B | 0.00 |
| United-Guardian (UG) | United States | $0.061B | 12.86 |
| Nephros (NEPH) | United States | $0.059B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.054B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.052B | 0.00 |
| Surface Oncology (SURF) | United States | $0.051B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.019B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.001B | 0.00 |
